Expert care for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) with advanced molecular testing, precision medicine, and comprehensive treatment protocols.
Specialized care for both NSCLC and SCLC with cutting-edge molecular profiling, immunotherapy combinations, and targeted therapies. We focus on early detection through low-dose CT screening and personalized treatment based on genetic mutations.
Annual screening for high-risk patients (smokers, age 50+) to detect lung cancer at early, treatable stages.
Comprehensive testing for EGFR, ALK, ROS1, BRAF, MET, and PD-L1 to guide targeted therapy selection.
Minimally invasive procedures to obtain tissue samples for accurate diagnosis and staging.
Chronic cough or change in cough, coughing up blood-streaked sputum, hoarseness.
Shortness of breath, chest pain worsened by deep breathing, wheezing, recurrent infections.
Unexplained weight loss, fatigue, loss of appetite, bone pain or headaches in advanced disease.
Cigarette smoking, secondhand smoke; cumulative pack-years correlate with risk.
Radon gas, asbestos, air pollution, occupational carcinogens (silica, diesel fumes).
Genetic predisposition, prior chest radiation, underlying lung disease (COPD).
Scheduled follow-ups and imaging studies to monitor treatment response.
Collaboration with pulmonologists, radiologists, and other specialists.
Managing side effects and improving quality of life during treatment.